Oxford Biomedica Plc Stock Analysis

OXBDF Stock  USD 4.43  0.71  19.09%   
Oxford Biomedica plc is undervalued with Real Value of 4.69 and Hype Value of 4.43. The main objective of Oxford Biomedica pink sheet analysis is to determine its intrinsic value, which is an estimate of what Oxford Biomedica plc is worth, separate from its market price. There are two main types of Oxford Biomedica's stock analysis: fundamental analysis and technical analysis.
The Oxford Biomedica pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Oxford Biomedica's ongoing operational relationships across important fundamental and technical indicators.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oxford Biomedica plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Oxford Pink Sheet Analysis Notes

About 63.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.69. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Oxford Biomedica plc had not issued any dividends in recent years. The entity had 1:50 split on the 30th of May 2018. Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom. Oxford Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 959 people.The quote for Oxford Biomedica plc is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Oxford Biomedica plc contact the company at 44 1865 783 000 or learn more at https://www.oxb.com.

Oxford Biomedica plc Investment Alerts

Oxford Biomedica plc is way too risky over 90 days horizon
Oxford Biomedica plc appears to be risky and price may revert if volatility continues
About 63.0% of the company shares are owned by institutional investors

Oxford Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 548.76 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Oxford Biomedica's market, we take the total number of its shares issued and multiply it by Oxford Biomedica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Oxford Profitablity

The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.1) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.1.

Technical Drivers

As of the 18th of July 2024, Oxford Biomedica holds the Coefficient Of Variation of 540.3, variance of 23.7, and Risk Adjusted Performance of 0.1218. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oxford Biomedica, as well as the relationship between them. Please check Oxford Biomedica plc information ratio, as well as the relationship between the value at risk and kurtosis to decide if Oxford Biomedica plc is priced some-what accurately, providing market reflects its current price of 4.43 per share. Given that Oxford Biomedica has information ratio of 0.1594, we recommend you to check out Oxford Biomedica plc's recent market performance to make sure the company can sustain itself at a future point.

Oxford Biomedica plc Price Movement Analysis

Execute Study
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Oxford Biomedica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Oxford Biomedica plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Oxford Biomedica Predictive Daily Indicators

Oxford Biomedica intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Oxford Biomedica pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Oxford Biomedica Forecast Models

Oxford Biomedica's time-series forecasting models are one of many Oxford Biomedica's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oxford Biomedica's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Oxford Pink Sheet Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Oxford Biomedica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oxford shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Oxford Biomedica. By using and applying Oxford Pink Sheet analysis, traders can create a robust methodology for identifying Oxford entry and exit points for their positions.
Oxford Biomedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of cell and gene therapy products in Europe and internationally. Oxford Biomedica plc was founded in 1995 and is headquartered in Oxford, the United Kingdom. Oxford Biomedical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 959 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Oxford Biomedica to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Equity Forecasting Now


Equity Forecasting

Use basic forecasting models to generate price predictions and determine price momentum
All  Next Launch Module

Complementary Tools for Oxford Pink Sheet analysis

When running Oxford Biomedica's price analysis, check to measure Oxford Biomedica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oxford Biomedica is operating at the current time. Most of Oxford Biomedica's value examination focuses on studying past and present price action to predict the probability of Oxford Biomedica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oxford Biomedica's price. Additionally, you may evaluate how the addition of Oxford Biomedica to your portfolios can decrease your overall portfolio volatility.
Find actively traded Exchange Traded Funds (ETF) in USA
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules